semaglutide cause heart problems cardiovascular outcomes align more closely with attained dose than achieved weight loss Wegovy Approved for Major Heart

This mechanistic depth is the basis for Phase 2 outcomes that exceeded all prior single- or dual-agonist research

Setting reminders can help, or linking your injections to a weekly routine or schedule can also make it easier to remember

Even so, an October 2025 Gallup poll reported that 12.4% of respondents to a nationally representative survey were taking this class of medication for weight loss

While statistically significant, this absolute risk increase is small compared to the baseline DVT rate in the general population (approximately 1-2 per 1,000 per year in adults over 40)

Stop paying

Consult your doctor before receiving the medicine